The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “ATMPs Quality Assurance Responsible”
Reference: 2026-43-01
Application deadline: until the position is filled
Number of vacancies: 1
At VHIO, we are setting up a new Clean room for the production of Advanced Therapies Medicinal Products (ATMPs). For the execution of this project, a multidisciplinary working group has been created from various departments within the centre. To complete it, we are looking for a quality assurance professional to participate in the commissioning of the room, implementing the quality system, and once operational, to be responsible for quality assurance.
The mission of the role will be to implement, control and maintain the GMP Quality Assurance System of the Advanced Therapies Accelerator Unit at VHIO. Reporting to the ATMP Clean Room’s Qualified Person. The position is funded by the Advanced Therapies Accelerator AECC Excellence Program.
Ensuring compliance with the GMP-ATMPs Standards in the Advanced Therapies Accelerator Unit’s manufacturing activities, regarding document management, creation, follow-up and evaluation of non-conformities/incidences, change controls and risk assessment. Also, monitoring of training and of the validations and qualifications performed to comply with the responsibilities and qualifications described in current GMPs regulations.
Quality Assurance: Responsible for monitoring and maintaining the quality management system under the responsibility of the Qualified Person. In general, responsible for ensuring compliance with GMP-ATMPs in the manufacturing activities of the Unit/organization.
In terms of document management: maintaining the quality documentation system, creation, follow-up and evaluation of non-conformities, changes, and risks, as well as monitoring training and validations/qualifications executed.
Job Objectives:
Guarantee the harmonization and effectiveness of the global quality system/elements (QMS) throughout the company and departments (R&D, Production, QC, Management), providing an overall view of quality assurance.
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO) has established itself as a cancer research center of proven excellence internationally. It is thanks to Josep's directorship and VHIO's optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d´Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d´Hebron University Hospital physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO's pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread and more effectively treating even the most undruggable tumour types.
VHIO's translation toward precision oncology.
